tirzepatide osa fda approval approves weight-loss drug Zepbound to treat sleep apnea Obstructive sleep apnea with obesity:

If you experience chest pain, fainting, or severe difficulty breathing, immediate medical care is necessary

As of January 2026, 13 states cover tirzepatide and other GLP-1 medications for weight loss

Prioritize stress management and quality sleep: Chronic stress and poor sleep can disrupt hunger hormones and contribute to weight gain

Lastly, patients undergoing same-day EGD-colonoscopy or EGD-flexible sigmoidoscopy were identified as the same cohort because they were all given a bowel prep prior to the procedure

Acknowledgments The authors thank Frank Meye for the valuable discussions, Bregje Titulaer for piloting previous related experiments

Mean glucose, standard deviation and GRI also showed greater improvement with AID in the type 1 diabetes group